Event Overview

Personalized medicine clearly has the potential to transform healthcare. Less clear, however, is the pathway to achieving that potential: What business models will work; what is government's role; and how might changing economic and political conditions impact the outlook for personalized medicine?

Leaders in business and policy will address these and other questions during this full day event on January 27, 2009 in Washington, D.C. As context for an informed discussion, this conference will offer a first look at the findings of a new Deloitte Center for Health Solutions national study on business models and the return on investment (ROI) in personalized medicine titled "The ROI for Targeted Therapies: Assessing the Barriers and Incentives for Adopting Personalized Medicine." Through a series of interactive discussions, participants will also examine policy proposals designed to create incentives or to address the challenges innovators are facing in getting products to market.

CONFERENCE REGISTRATION AND FEES

Seating is limited; therefore, registration is required for all attendees.